Cargando…

Understanding the structure–property relationship of bispecific monoclonal antibodies with Fc site-specific substitutions

Development of novel bispecific antibody (bsAb) platforms offers unprecedented opportunities for a wide variety of therapeutic applications. However, the expression and manufacturing of bsAbs with desired structures can be challenging. Owing to the uniqueness of each bsAb platform, more comprehensiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Bo, Zhao, Yunlong, Adaniya, Stephanie, Fu, Yue, Moon, Youmi, Heftel, Justin, Chen, Shuzhen, Xiao, Hui, Li, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294755/
https://www.ncbi.nlm.nih.gov/pubmed/37357447
http://dx.doi.org/10.1080/19420862.2023.2228006
_version_ 1785063258677313536
author Zhao, Bo
Zhao, Yunlong
Adaniya, Stephanie
Fu, Yue
Moon, Youmi
Heftel, Justin
Chen, Shuzhen
Xiao, Hui
Li, Ning
author_facet Zhao, Bo
Zhao, Yunlong
Adaniya, Stephanie
Fu, Yue
Moon, Youmi
Heftel, Justin
Chen, Shuzhen
Xiao, Hui
Li, Ning
author_sort Zhao, Bo
collection PubMed
description Development of novel bispecific antibody (bsAb) platforms offers unprecedented opportunities for a wide variety of therapeutic applications. However, the expression and manufacturing of bsAbs with desired structures can be challenging. Owing to the uniqueness of each bsAb platform, more comprehensive and customized structural characterization is particularly important to understand the chemical or biological reactivity of bsAbs, as well as to guide process development, risk assessment, and manufacturing. In this work, we performed higher order structure characterization of the Regeneron bsAb platform with Fc site-specific substitutions through hydrogen deuterium exchange mass spectrometry (HDX-MS). Structural deprotection was identified at the C(H)2-C(H)3 interface in the Fc domain, owing to the site-specific substitutions. The structural deprotection was found to correlate with the decreased conformational stability of Fc domain. Under oxidative and thermal stress conditions, the Met residues located near the structurally deprotected region were identified to be susceptible to oxidation. In addition, the introduction of substitutions in the bsAb Fc resulted in a slight reduction of its binding affinity to the neonatal Fc receptor (FcRn). The detailed structural elucidation by HDX-MS improves understanding of the structure–property relationship of the Regeneron bsAb format, thus greatly aiding in process development, risk assessment, and manufacturing.
format Online
Article
Text
id pubmed-10294755
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-102947552023-06-28 Understanding the structure–property relationship of bispecific monoclonal antibodies with Fc site-specific substitutions Zhao, Bo Zhao, Yunlong Adaniya, Stephanie Fu, Yue Moon, Youmi Heftel, Justin Chen, Shuzhen Xiao, Hui Li, Ning MAbs Report Development of novel bispecific antibody (bsAb) platforms offers unprecedented opportunities for a wide variety of therapeutic applications. However, the expression and manufacturing of bsAbs with desired structures can be challenging. Owing to the uniqueness of each bsAb platform, more comprehensive and customized structural characterization is particularly important to understand the chemical or biological reactivity of bsAbs, as well as to guide process development, risk assessment, and manufacturing. In this work, we performed higher order structure characterization of the Regeneron bsAb platform with Fc site-specific substitutions through hydrogen deuterium exchange mass spectrometry (HDX-MS). Structural deprotection was identified at the C(H)2-C(H)3 interface in the Fc domain, owing to the site-specific substitutions. The structural deprotection was found to correlate with the decreased conformational stability of Fc domain. Under oxidative and thermal stress conditions, the Met residues located near the structurally deprotected region were identified to be susceptible to oxidation. In addition, the introduction of substitutions in the bsAb Fc resulted in a slight reduction of its binding affinity to the neonatal Fc receptor (FcRn). The detailed structural elucidation by HDX-MS improves understanding of the structure–property relationship of the Regeneron bsAb format, thus greatly aiding in process development, risk assessment, and manufacturing. Taylor & Francis 2023-06-25 /pmc/articles/PMC10294755/ /pubmed/37357447 http://dx.doi.org/10.1080/19420862.2023.2228006 Text en © 2023 Regeneron Pharmaceuticals. Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
spellingShingle Report
Zhao, Bo
Zhao, Yunlong
Adaniya, Stephanie
Fu, Yue
Moon, Youmi
Heftel, Justin
Chen, Shuzhen
Xiao, Hui
Li, Ning
Understanding the structure–property relationship of bispecific monoclonal antibodies with Fc site-specific substitutions
title Understanding the structure–property relationship of bispecific monoclonal antibodies with Fc site-specific substitutions
title_full Understanding the structure–property relationship of bispecific monoclonal antibodies with Fc site-specific substitutions
title_fullStr Understanding the structure–property relationship of bispecific monoclonal antibodies with Fc site-specific substitutions
title_full_unstemmed Understanding the structure–property relationship of bispecific monoclonal antibodies with Fc site-specific substitutions
title_short Understanding the structure–property relationship of bispecific monoclonal antibodies with Fc site-specific substitutions
title_sort understanding the structure–property relationship of bispecific monoclonal antibodies with fc site-specific substitutions
topic Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294755/
https://www.ncbi.nlm.nih.gov/pubmed/37357447
http://dx.doi.org/10.1080/19420862.2023.2228006
work_keys_str_mv AT zhaobo understandingthestructurepropertyrelationshipofbispecificmonoclonalantibodieswithfcsitespecificsubstitutions
AT zhaoyunlong understandingthestructurepropertyrelationshipofbispecificmonoclonalantibodieswithfcsitespecificsubstitutions
AT adaniyastephanie understandingthestructurepropertyrelationshipofbispecificmonoclonalantibodieswithfcsitespecificsubstitutions
AT fuyue understandingthestructurepropertyrelationshipofbispecificmonoclonalantibodieswithfcsitespecificsubstitutions
AT moonyoumi understandingthestructurepropertyrelationshipofbispecificmonoclonalantibodieswithfcsitespecificsubstitutions
AT hefteljustin understandingthestructurepropertyrelationshipofbispecificmonoclonalantibodieswithfcsitespecificsubstitutions
AT chenshuzhen understandingthestructurepropertyrelationshipofbispecificmonoclonalantibodieswithfcsitespecificsubstitutions
AT xiaohui understandingthestructurepropertyrelationshipofbispecificmonoclonalantibodieswithfcsitespecificsubstitutions
AT lining understandingthestructurepropertyrelationshipofbispecificmonoclonalantibodieswithfcsitespecificsubstitutions